files/journal/2022-09-03_18-51-40-000000_599.png

Research Journal of Medical Sciences

ISSN: Online 1993-6095
ISSN: Print 1815-9346
About US
Editors
Issues
Pages
Indexed in

Research Journal of Medical Sciences, Volume 12, Issue 6 (2018)

References

  1. Rogers, S., R.L. McIntosh, N. Cheung, L. Lim and J.J. Wang et al., 2010. The Prevalence of Retinal Vein Occlusion: Pooled Data from Population Studies from the United States, Europe, asia, and Australia. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmology, 117: 1-10.
  2. Jaulim, A., B. Ahmed, T. Khanam and I.P. Chatziralli, 2013. BRANCH RETINAL VEIN OCCLUSIO. Nepidemiology, pathogenesis, risk factors, clinical features, diagnosis, and complications. An update of the literature 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Retina, 33: 1-10.
  3. Campochiaro, P.A., 2015. Molecular pathogenesis of retinal and choroidal vascular diseases. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Prog. Retinal Eye Res., 49: 1-10.
  4. Hayreh S.S., 1994.  Retinal vein occlusion. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Indian J Ophthalmol., 42: 1-10.
  5. Central Vein Occlusion Study Group., 1997.  Natural history and clinical management of central retinal vein occlusion.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Arch Ophthalmol., 15: 1-10.
  6. Branch Vein Occlusion Study Group., 1984.  Argon laser photocoagulation for macular edema in branch vein occlusion.   0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Arch Ophthalmol., 102: 1-10.
  7. Cugati S., et al., 2006. Ten-Year Incidence of Retinal Vein Occlusion in an Older Population: the Blue Mountains Eye Study.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Arch. Ophthalmol., 124: 1-10.
  8. Klein R., S.E. Moss, S.M. Meuer and B.E. Klein., 2000. The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Trans Am Ophthalmol Soc., 98: 1-10.
  9. Coscas G., S. Wolf, F. Bandello, A. Loewenstein, T. Ishibashi and J.B. Jonas, et al., 2017. Guidelines for the management of retinal vein occlusion by the European Society of Retina Specialists (EURETINA).  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmologica., 237: 1-10.
  10. Spaide R.F., J.M. Klancnik and M.J. Cooney., 2015.  Retinal vein occlusion.   0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Retina., 35: 1-10.
  11. Haller, J.A., F. Bandello, R. Belfort, M.S. Blumenkranz and M. Gillies et al., 2011. Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion: twelve-month study results.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmology, 118: 1-10.
  12. Boyer, D.S., Y.H. Yoon, R. Belfort, F. Bandello and R.K. Maturi et al., 2014. Three-Year, Randomized, Sham-Controlled Trial of Dexamethasone Intravitreal Implant in Patients with Diabetic Macular Edema. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmology, 121: 1-10.
  13. Campochiaro P.A. and C.C. Wykoff., 2016. . VEGF inhibition: new and future directions. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Retina., 36: 1-10.
  14. Pe'er, J., R. Folberg, A. Itin, H. Gnessin, I. Hemo and E. Keshet, 1996. Upregulated expression of vascular endothelial growth factor in proliferative diabetic retinopathy. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmol., 103: 1-10.
  15. Rosenfeld, P.J., D.M. Brown, J.S. Heier, D.S. Boyer, P.K. Kaiser, C.Y. Chung and R.Y. Kim, 2006. Ranibizumab for Neovascular Age-Related Macular Degeneration. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, New Engl. J. Med., 355: 1-10.
  16. Avitabile T., T. Trabucco, A. Mancuso, A. Longo, A. Tinebra and S.M. Recupero., 2008.  Intravitreal bevacizumab for macular edema secondary to retinal vein occlusion. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Retina., 28: 1-10.
  17. Russo V., M. Varano, S. Pinackatt, G. Raia, T. Avitabile and M. Reibaldi, et al., 2011. Intravitreal bevacizumab for macular edema secondary to retinal vein occlusion: a multicenter study.   0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Eur J Ophthalmol., 21: 1-10.
  18. Russo V., D.J. D’Amico and M. Reibaldi., 2013. Intravitreal bevacizumab for retinal vein occlusion: a systematic review.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J Ophthalmol., Vol. 2013. 0 1-10.
  19. Ferrara, N., 2004. Vascular Endothelial Growth Factor: Basic Science and Clinical Progress. 0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Endocr. Rev., 25: 1-10.
  20. Campochiaro P.A., G. Hafiz, S.M. Shah, F.Q. Silva, D.M. Brown and D.S. Boyer, et al., 2010. Ranibizumab for macular edema following branch retinal vein occlusion: six-month primary end point results of a phase III study.   0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmology., 117: 1-10.
  21. Brown, D.M., P.A. Campochiaro, R.P. Singh, Z. Li and S. Gray et al., 2010. Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: six-month primary end point results of a phase III study. Ophthalmology, 117: 1124-11330.
  22. Hillier R.J., L. Lee, D. Wong and T.L. Jackson., 2017.  Anti-VEGF therapy for macular edema secondary to retinal vein occlusion: a systematic review and meta-analysis.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Eye (Lond)., 31: 1-10.
  23. Thulliez M., C. Roubeix, Y. Zerbib and M. Mauget-Faysse., 2016. Systemic safety of intravitreal bevacizumab in retinal vein occlusion: a literature review.  0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, J Ophthalmol., Vol. 2016. 0 1-10.
  24. Bressler N.M., W.T. Beaulieu, A.R. Glassman, L.M. Jampol, S.B. Bressler and F.L. Ferris, et al., 2016. . Persistent macular thickening after ranibizumab treatment for diabetic macular edema with vision impairment.   0 0, January 01-01, 1970, In: 0, 0 (Ed.)., 0 Edn., 0, 0, ISBN-1: 0, Ophthalmology., 123: 1-10.